CENTRALISED
LABORATORY NETWORK – SCI & TECH
News:
India joins Centralised
Laboratory Network (CLN) for testing vaccines
What's
in the news?
●
India has joined the Centralized
Laboratory Network (CLN) which currently has 15 partner facilities in 13 countries
that works to test vaccines which can be used during pandemic, epidemic disease
outbreak.
Centralised
Laboratory Network:
●
CLN is a part of the Coalition for Epidemic Preparedness Innovations (CEPI)
and the Network is the largest global group which has standardized methods and materials for testing.
Members:
●
The laboratories
initially selected for this vaccine-assessment network are: Nexelis
(Canada) and Public Health England (PHE, UK), VisMederi Srl (Italy),
Viroclinics-DDL (The Netherlands), icddr,b (formerly International Centre for
Diarrhoeal Disease Research, Bangladesh), and Translational Health Sciences and
Technological Institute (THSTI, India).
●
The
new members of the CLN now are Indian Council of Medical Research-National
Institute of Virology (ICMR-NIV),
Institute Pasteur de Dakar (IPD) (Senegal), KAVI Institute of Clinical Research
(KAVI ICR) & University of Nairobi Institute of Tropical and Infectious
Diseases (UNITID) (Kenya), Synexa Life Sciences (South Africa) and Uganda Virus
Research Institute (UVRI) (Uganda).
CEPI:
●
CEPI is an innovative partnership between public, private, philanthropic, and
civil organizations, launched at Davos in 2017, to develop vaccines to stop
future epidemics.
●
The Department
of Biotechnology, Ministry of Science & Technology is implementing the
Ind-CEPI mission titled ‘India Centric Epidemic Preparedness through Rapid
Vaccine Development: Supporting Indian Vaccine Development Aligned with the
Global Initiative of the Coalition for Epidemic Preparedness Innovations
(CEPI)’.
Aim: